Optimizing a deployable high efficacy malaria vaccine

Project Information

OptiMalVax

Grant agreement ID: 733273

DOI 10.3030/733273

Project closed

EC signature date 9 December 2016

Start date 1 January 2017

End date 31 December 2022

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost € 23 741 228,75

EU contribution € 20 050 441,25

Coordinated by

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
United Kingdom

• An effective vaccine for the deadliest malaria
  EN